Saturday 17 October 2026
Export UCFI’s income statement to Excel — free account
CN Healthy Food Tech Group Corp
UCFI Consumer Defensive Packaged Foods
CN Healthy Food Tech Group Corp’s revenue for fiscal 2025 (year ended December 2025) was $27.8 million, up 144.6% from fiscal 2024. In the quarter to June 2026, revenue grew 17.1%, EPS fell 2.12% and free cash flow fell 356.5%, each against the same quarter a year earlier.
5.51
0.00
0.00%
Follow UCFI
| Dec '22 | Dec '24 | Dec '25 | |
|---|---|---|---|
P/E ratio |
— | 22.67 | 32.03 |
Altman Z-Score |
— | 8.16 | 8.71 |
P/S ratio |
— | 0.00 | 9.70 |
Altman Z″-Score (non-manufacturers) |
— | 1.80 | 5.31 |
P/FCF ratio |
— | 0.00 | 0.00 |
P/Operating CF |
— | 24.22 | (80.68) |
Beneish M-Score |
— | — | (0.03) |
P/B ratio |
— | 45.39 | 13.55 |
Price to Tangible BV |
— | 60.47 | 15.68 |
EV/Sales |
— | 0.00 | 8.51 |
EV/EBITDA |
— | 0.00 | 19.06 |
EV/Operating CF |
— | 0.00 | (26.12) |
EV/FCF |
— | 0.00 | (24.11) |
Quick Ratio |
— | 1.04 | 1.34 |
Current Ratio |
— | 1.10 | 1.50 |
Net Debt/EBITDA |
— | (7.22) | (2.66) |
Debt/Assets |
0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 0.00 | 0.00 |
Asset Turnover |
— | 0.45 | 0.58 |
Operating CF/Net income |
— | 10.54 | (1.08) |
Capex/Depreciation |
— | (0.27) | (1.23) |
| — | 0.00% | 54.83% | |
| — | 15.75% | 17.62% | |
ROIC |
— | 0.00% | 0.00% |
Return on Tangible Assets |
— | 49.24% | 49.81% |
Average Days of Receivables |
— | 0.03 | 0.00 |
Research and Development Expense of Revenue |
— | 0.06% | 0.48% |
Selling, General and Administrative Expense of Revenue |
— | 17.58% | 23.43% |
Intangible Assets out of Total Assets |
0.00 | 0.05 | 0.06 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% |
Graham Net Nets |
— | 0.01 | 0.04 |
Graham Number |
— | 0.00 | 1.25 |
Earnings Yield |
— | 4.41% | 3.12% |
Free Cash Flow Yield |
— | 0.00% | (3.64%) |
Revenue per Share |
— | 0.24 | 0.57 |
Operating CF per Share |
— | 0.88 | (0.19) |
Capex per Share |
— | 0.00 | (0.02) |
Free Cash Flow per Share |
— | 0.88 | (0.20) |
Cash per Share |
— | 0.87 | 0.68 |
Shareholders Equity per Share |
— | 0.23 | 0.41 |
Interest Debt per Share |
— | 0.00 | 0.00 |
Book value per Share |
— | 0.23 | 0.41 |
Free Cash Flow |
— | 42.06 | (9.80) |
Working Capital |
— | 4.08 | 12.28 |
Capital Expenditures |
— | (0.05) | (0.75) |
Net Current Asset Value |
— | 4.08 | 12.04 |
EV/EBIT |
— | 0.00 | 20.05 |
Capex to Sales |
— | 0.00 | 0.03 |
Price to Operating Income |
— | 0.00 | 22.86 |
| Other line items | |||
Depreciation/Fixed assets |
— | 0.05 | 0.13 |
Cash ROIC |
— | 80.52% | (18.53%) |
Accounts Receivable Turnover |
— | 0.00 | 50,472.55 |
Accounts Payable Turnover |
— | 0.00 | 28.56 |
Inventory Turnover |
— | 0.00 | 8.47 |
Average Days of Payables |
— | 56.17 | 2.70 |
Days of Inventory on Hand |
— | 120.04 | 37.36 |
Average Receivables |
— | — | 0.00 |
Average Payables |
— | — | 0.33 |
Average Inventory |
— | — | 1.10 |
Average Assets |
— | 25.38 | 47.74 |
Average Common Equity |
— | — | 15.34 |
Columns are period end dates